Description

Laferobion lyophilisate for solution for injections 1 ml. №10 vial

Ingredients:

Each vial contains: Interferon alfa-2b (recombinant human interferon alpha-2b) 100000 IU.

Dosage:

The dosage is individual and depends on the indication. The solution is administered by intramuscular or subcutaneous injection.

Indications:

Laferobion is indicated for the treatment of various viral infections, including hepatitis B and C, genital warts, and certain types of leukemia.

Contraindications:

Do not use Laferobion in case of hypersensitivity to interferon alfa-2b or any other component of the product. It is contraindicated in patients with autoimmune hepatitis.

Directions:

The solution should be prepared according to the instructions provided. It is important to follow aseptic techniques during preparation and administration.

Scientific Evidence:

Studies have shown that interferon alfa-2b, the active ingredient in Laferobion, has potent antiviral and antiproliferative effects. It works by modulating the immune response to combat viral infections and inhibit the growth of cancer cells. Clinical trials have demonstrated the efficacy of interferon alfa-2b in improving viral clearance rates and reducing the progression of certain malignancies.

Additional Information:

Laferobion lyophilisate for solution for injections is a well-established treatment option for viral infections and certain types of cancer. It is important to discuss the potential benefits and risks of treatment with your healthcare provider. Adherence to the prescribed dosage and regimen is crucial for optimal outcomes.